Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including...
angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 28, 2022 10:13am
$HEM grants worldwide field license to PreCerv Inc.
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central
...more
(9)
•••
maikaljarry
X
View Profile
View Bullboard History
Post by
maikaljarry
on Jun 28, 2022 9:23am
$HEM market cap shoot up to $17 Million
$HEM have developed and established a firm market cap which has been on the rise steadily since the listing of the stock on TSX-V, currently the cap valuation is $17.404Million.
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 28, 2022 8:42am
Data audit efficiently executed, results came out to be auth
Hemostemix have been handed back its intellectual property consisting of all the clinical trial data of ACP-01 which was long unlawfully held by Accudata and Aspire Health Science, the data audit post
...more
(1)
•••
Pabloparker
X
View Profile
View Bullboard History
Post by
Pabloparker
on Jun 28, 2022 7:47am
Hemostemix Inc. (TSXV: HEM)(OTC: HMTXF) The Numero Uno Stock
www.marketwatch.com/.../hemostemix-inc-tsxv-hem-otc-hmtxf-the-numero-uno-stock-investment-in-the-game-2022-06-28
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 28, 2022 5:44am
The big green blob on graph. Buying by insiders !!
https://m.canadianinsider.com/node/7?menu_tickersearch=THC+%7C+THC+Biomed+Intl
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 28, 2022 5:41am
I am glad i bought and sold made profit. Reinvested in THC
Financials due in a couple of days. I think their biscuits are selling like hot cakes . A lot of buying buy the CEO and CFO lately. Looks like a big green blob of insider buying on the graph. DYODD
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 27, 2022 3:55pm
$HMTXF outstanding shares and public float summary
$HMTXF has successfully offered and issued an aggregate of 68.2 Million to the shareholders globally in terms of outstanding shares, and a total of 19.34 Million shares are available for the general
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 27, 2022 3:32pm
$HMTXF outstanding shares and public float summary
$HMTXF has successfully offered and issued an aggregate of 68.2 Million to the shareholders globally in terms of outstanding shares, and a total of 19.34 Million shares are available for the general
...more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 27, 2022 2:52pm
Hemostemix achieves lawful possession of all its missing int
All the intellectual data including all phase 2 clinical trial data, all the historical data from hemostemix Israel, and the randomized table required to analyze North-American and South-African ACP
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 27, 2022 2:49pm
$HEM grants worldwide field license to PreCerv Inc.
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central
...more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 27, 2022 2:47pm
$HMTXF common share and warrant elaboration
The recently announced private placement of 15 million units has put the entire OTC in awe, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles
...more
(6)
•••
Tradeconnects
X
View Profile
View Bullboard History
Post by
Tradeconnects
on Jun 27, 2022 12:14pm
$HEM daily trade volume consumption
$HEM offers its investors a total of 122,293 in terms of average volume for daily trade related activities, the daily volume pump of $HEM is 122,293 units on an average
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 27, 2022 11:58am
$HEM on recent prolific stock run on the TSX-V index
$HEM observed a major bound on the TSX-V that left the entire market at shock, the shares are trading live at the best buying price of $0.2500 with a significant spike of 2%.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 27, 2022 11:46am
$HEM expansion of the common share and warrant within the of
The recently announced private placement of 15 million units, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles the holder to acquire one common
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 27, 2022 11:39am
Existing shareholder exemption of the Hemostemix offer
The offering constituting the private non-brokered placement of 15 Million units is only available to existing shareholders of the company, who as of the closing of business on May 16, 2022 hold
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project